RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial offers hope for healing 'Butterfly Skin' wounds
Disease control OngoingThis study is testing whether a new gene therapy called FCX-007 can help heal wounds in people with recessive dystrophic epidermolysis bullosa (RDEB), a painful and severe genetic condition that causes fragile, blistering skin. The therapy involves taking a patient's own skin cel…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New eye drops aim to soothe painful eye damage in 'Butterfly Skin' disease
Symptom relief OngoingThis study is testing whether a new eye drop called ELK-003 can help reduce painful eye problems in people with epidermolysis bullosa (EB), a condition that causes fragile skin and frequent corneal abrasions. For 6 months, 20 participants will use the drops 6 times daily to see i…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1 • Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC